I looked a time or two today, but was very busy most of the day. Ascm on the ask this morning, they are shorting I believe, probably playing off the latest offering and the convertible note. I am ready for the TNBC trial to start also, and hopeful the BLA submission with just 500mg data, then the fda approving the mono pivotal trial. We need to shake off these trolls that are trying their best to discredit the company.

Speaking of that I just saw fine is going incorrectly with the $0.2669/sh. She might be the most arrogant poster I've seen. Once she believes something, her objectivity goes out the window. She becomes lost in that line of thinking, unable to escape. Just like her thinking they needed safety data from the mono pivotal trial.